Immunic (IMUX) Accumulated Depreciation (2013 - 2015)

Immunic (IMUX) has 3 years of Accumulated Depreciation data on file, last reported at $7.4 million in Q2 2015.

• For the quarter ending Q2 2015, Accumulated Depreciation rose 16.85% year-over-year to $7.4 million; the trailing twelve-month figure through Jun 2015 stood at $7.4 million (up 16.85% YoY), and the FY2014 full-year result was $6.8 million, up 17.78% from the prior year.
• Accumulated Depreciation climbed to $7.4 million in Q2 2015, from $7.1 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $7.4 million in Q2 2015 to a low of $5.8 million in Q4 2013.
• A 3-year average of $6.6 million and a median of $6.6 million in 2014 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation rose 17.78% in 2014 and gained 16.85% in 2015, its largest moves.
• Tracing IMUX's Accumulated Depreciation over 3 years: stood at $5.8 million in 2013, then advanced by 17.78% to $6.8 million in 2014, then grew by 8.57% to $7.4 million in 2015.
• Business Quant data shows IMUX's Accumulated Depreciation at $7.4 million in Q2 2015, $7.1 million in Q1 2015, and $6.8 million in Q4 2014.